0B68 Pestell, Richard G. - Thomas Jefferson University - Thomas Jefferson University
rpg102

Richard G. Pestell, MD, PhD

Contact Dr. Pestell

233 South 10th Street
Room 1050
Philadelphia, PA 19107

(215) 503-5692
(215) 503-9334 fax

Most Recent Peer-reviewed Publications

  1. Antibiotics for cancer therapy
  2. BCL-2 family protein, BAD is down-regulated in breast cancer and inhibits cell invasion
  3. Sirt1-deficient mice have hypogonadotropic hypogonadism due to defective GnRH neuronal migration
  4. CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines
  5. Cyclin D1 integrates estrogen-mediated DNA damage repair signaling
  6. CAPER, a novel regulator of human breast cancer progression
  7. Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: Past and present
  8. Long and noncoding RNAs (lnc-RNAs) determine androgen receptor dependent gene expression in prostate cancer growth in vivo
  9. Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation
  10. Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint
  11. MicroRNA-mediated cancer metastasis regulation via heterotypic signals in the microenvironment
  12. Acetylation-defective mutants of PparĪ³ are associated with decreased lipid synthesis in breast cancer cells
  13. The metastatic potential of triple-negative breast cancer is decreased via caloric restriction-mediated reduction of the miR-17~92 cluster
  14. miR-17/20 sensitization of breast cancer cells to chemotherapy-induced apoptosis requires Akt1
  15. Caveolin-1 regulates the anti-atherogenic properties of macrophages
  16. The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells
  17. The potential to target CCL5/CCR5 in breast cancer
  18. Loss of sirt1 promotes prostatic intraepithelial neoplasia, reduces mitophagy, and delays park2 translocation to mitochondria
  19. MiR-221/222 promotes S-Phase entry and cellular migration in control of basal-like breast cancer
  20. Cyclin D1 induction of dicer governs microRNA processing and expression in breast cancer
0